Centessa Pharma PLC (ADR) Live Stock Price Today, Share Analysis and Chart

Name: Centessa Pharmaceuticals plc - ADR: Is Infosys Ltd. worth buying?
Item: Centessa Pharmaceuticals plc - ADR
Rating: 1.69550
Author: Trendlyne DVM scores

about

Centessa Pharmaceuticals PLC is a clinical-stage biotechnology company pioneering a new class of therapeutics in orexin-based neuroscience. The group is developing a franchise of small molecule orexin receptor 2 (OX2R) agonists designed to address ne...

39.42 -0.03 (-0.08%)

Near 52W High of $40.26

3.0M

XNAS Volume

XNAS 30 Apr, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

3.0 / 100

Technically Moderately Bullish

64.8 / 100

1Yr Price target upside is 13%

7 analysts

Centessa Pharma PLC (ADR) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Centessa Pharma PLC (ADR) Live Stock Price Today, Share Analysis and Chart

Centessa Pharmaceuticals PLC is a clinical-stage biotechnology company pioneering a new class of therapeutics in orexin-based neuroscience. The group is developing a franchise of small molecule orexin receptor 2 (OX2R) agonists designed to address ne...

Near 52W High of $40.26

SWOT Analysis

Centessa Pharma PLC (ADR) Live Price Chart